Hims, Amazon and Hers Health

Hims & Hers’ stock tumbles on Amazon’s latest disruptive foray into healthcare
Hims & Hers Health Inc. shares tumbled 22% Thursday, on concerns that Amazon.com Inc.’s latest push into healthcare will disrupt Hims & Hers’ business. Amazon One Medical launched a new service Thursday that offers upfront pricing for telehealth visits for a range of issues and ailments — including men’s hair loss,
Hims & Hers Health: The Amazon Curse Is Being Overstated
Hims & Hers Health's stock dropped 25% due to Amazon’s competition. Learn why HIM stock's 38% upside and strong growth make it a compelling buy.
Hims & Hers Stock Drops After Amazon Says It Will Offer Hair-Loss Treatments
Shares of Hims & Hers slid after Amazon.com said it would offer cheap treatments for concerns like hair loss, skin care and erectile dysfunction, directly competing with the telehealth startup. Amazon on Thursday launched the treatments through its One Medical telehealth service,
Amazon's push into telehealth knocks shares of Hims & Hers
Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers upfront pricing for telehealth visits.
Hims & Hers drops 22% on Amazon competition concerns (update)
Hims & Hers (HIMS) fell 22% after Amazon (AMZN) announced it was entering the hair loss and erectile dysfunction treatment markets through its telehealth unit. Read more here.
Hims & Hers Shares Drop Following Amazon's Expansion into Telehealth
Hims & Hers Health ( HIMS, Financials) shares slumped 24.5% on Thursday as Amazon ( AMZN, Financials) expanded into hair loss and erectile dysfunction treatment sectors; shares are recovering somewhat, up 4.3% in Friday's pre-market trading.
Amazon Gets Into the Boner Pill Business, Hims Stock Goes Limp
Amazon acquired primary care provider One Medical for $3.9 billion in 2022, and fills prescriptions through Amazon One Medical. Medications are packaged in standard Amazon packaging, so nobody will know you’re ordering boner pills.
Hold Rating for Hims & Hers Health Amidst Competitive Pressure from Amazon’s Telehealth Services
Citi analyst Daniel Grosslight has maintained their neutral stance on HIMS stock, giving a Hold rating on November 6. Daniel
Amazon One Medical launches service to compete with Hims & Hers
The tech giant said it would offer upfront, monthly pricing for customers seeking consultations and medications for five conditions including erectile dysfunction and men’s hair loss.
Hims & Hers stock falls as Amazon launches Telehealth offering
Shares of Hims & Hers Health, Inc. (HIMS) dropped over 15% Thursday following Amazon’s announcement of new telehealth treatment options aimed at providing low-cost care for a range of health and beauty concerns,
Hims & Hers drops 17% as Amazon rolls out expanded telehealth service
Shares of telehealth services provider Hims & Hers (NYSE:HIMS) fell 17% in morning trading Thursday after Amazon (NASDAQ:AMZN) announced it was launching an expanded pay-per-visit telehealth service,
Amazon launches fixed pricing for treatment of conditions such as hair loss. Hims & Hers stock drops 24%
Amazon announced Prime members can access new upfront pricing for treatment of five common conditions such as erectile ...
Hims & Hers Health Stock Is Tumbling Thursday: What's Going On?
Hims & Hers Health Inc (NYSE:HIMS) shares are trading lower in possible response to Amazon.com Inc's (NASDAQ:AMZN) new ...
Hims & Hers launches GLP-1 tracker in response to FDA's shortage decision
Hims & Hers (HIMS) is launching a new GLP-1 tracker in its efforts to fight back against the FDA’s decision to end compounded ...
Hosted on MSN2d
Hims & Hers Stock Gains 31.1% Since Q3 Earnings: What's Next?
Hims & Hers Health, Inc.’s HIMS investors are reaping some gains from the stock of late. Shares of the San Francisco, ...
Benzinga.com3d
Unpacking the Latest Options Trading Trends in Hims & Hers Health
Investors with a lot of money to spend have taken a bullish stance on Hims & Hers Health HIMS. And retail traders ...